Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
COAG compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name
COAG
Hemab Therapeutics Holdings, Inc.
Change
Mkt cap
Revenue
Revenue
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
COAG
Hemab Therapeutics Holdings, Inc.
vs
AMGN
Amgen Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
COAG: latest quarter not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
COAG, solid
AMGN, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only COAG
2
NVO
Novo Nordisk A/S
supplier
GMAB
Genmab A/S
supplier
Shared
0
No shared counterparties.
Only AMGN
12
PODD
Insulet
supplier
CYTK
Cytokinetics
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
LGND
Ligand Pharmaceuticals
supplier
Role chip = supplier or customer
Source: SEC EDGAR
8 more · AMGN chain
›
COAG
Hemab Therapeutics Holdings, Inc.
Change
44.34
▲
+2.88%
Mkt cap
$1.3B
Revenue
—
Revenue
—
AMGN
Amgen Inc
Change
480.80
▲
+4.24%
Regular session
Nov 4 '26
Mkt cap
$249.4B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
vs
Compare
Regular session
Nov 4 '26
COAG
Hemab Therapeutics Holdings, Inc.
vs
AMGN
Amgen Inc
44.34
▲
+2.88%
Price
480.80
▲
+4.24%
$1.3B
Mkt cap
$249.4B
—
Revenue
$10.4B
Q3 FY26
—
Revenue
$36.8B
FY25
Change
Change
COAG
44.34
▲
+2.88%
vs
AMGN
480.80
▲
+4.24%
Regular session
Nov 4 '26